|
|
 |
|
Viewing report
|
|
|
|
Antisense Therapy: Technical Aspects and Commercial Opportunities
Business Insights, March 2000
A review of the spectrum of antisense technologies reveals that considerable progress has been made during the past decade. This is more than in any other biopharmaceutical segment.
This report discusses the key antisense technologies, which have an impact on drug discovery and molecular diagnostics. Prominent among these are antisense gene therapy, ribozymes, triple helix forming oligonucleotides and peptide nucleic acid (PNA).
Customers who bought this item also bought
RNAi: Broad Application, Expansive Opportunity, 2nd Edition
Personalized Medicine - Scientific and Commercial Aspects
Chemotherapy Market Insights, 2006-2016: A Critical Analysis of Cancer Research, Treatments, Pipelines, and Commercial Opportunities
Gene Therapy - Technologies, Markets and Companies
Melanoma Therapeutics: Which Strategy Will Take Us There?
The Global Image Dermatology Drug Market, 2005-2012: High-Growth Opportunities in Aesthetic Medicine
Psychopharmacotherapy Market Insights: Obstacles and Opportunities in Mood Disorders and Cognitive Impairment, 2005-2012
Antisense cancer therapies
|
|
|
|
